The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating significant fundamental deterioration. While the company shows positive profit margins and revenue growth, these are completely overshadowed by a catastrophic price collapse, with a 5-year decline of 98.5% and a 0/100 technical trend. The extreme Price-to-Book ratio of 0.05 suggests the market views the asset as nearly worthless or a wasting instrument. Overall, the lack of analyst coverage and poor insider sentiment reinforce a high-risk, bearish outlook.